1. Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative
- Author
-
Honton, Benjamin, Lipiecki, Janusz, Monségu, Jacques, Leroy, Fabrice, Benamer, Hakim, Commeau, Philippe, Motreff, Pascal, Cayla, Guillaume, Banos, Jean Luc, Bouchou, Gael, Laperche, Clémence, Farah, Bruno, Rangé, Grégoire, Lefevre, Thierry, Amabile, Nicolas, Clinique Pasteur [Toulouse], CHU Clermont-Ferrand, Groupe Hospitalier Mutualiste [Grenoble] (GHM), Institut Pascal (IP), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)-Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA)-Université Clermont Auvergne (UCA), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Hôpitaux de Chartres [Chartres], Hôpital Privé Jacques Cartier [Massy], Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), and Institut Mutualiste de Montsouris (IMM)
- Subjects
In-stent restenosis ,MESH: Humans ,Constriction, Pathologic ,Coronary Angiography ,Coronary calcification ,MESH: Coronary Angiography ,Coronary Restenosis ,MESH: Stents ,MESH: Constriction, Pathologic ,Percutaneous Coronary Intervention ,Treatment Outcome ,MESH: Lithotripsy ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,MESH: Coronary Restenosis ,Lithotripsy ,Intravascular lithotripsy ,Humans ,Stents ,Cardiology and Cardiovascular Medicine ,MESH: Percutaneous Coronary Intervention ,MESH: Treatment Outcome - Abstract
International audience; Background: Intravascular lithotripsy (IVL) is a promising new technology for disrupting de-novo calcified coronary lesions (DNL) before percutaneous coronary intervention (PCI). We assessed 12-month outcomes of IVL in patients undergoing PCI for DNL or intra stent restenosis (ISR) lesions related to device underexpansion.Methods: Prospective analysis of patients in the multicentre all-comers French Shock Initiative IVL registry. The primary safety endpoints in this analysis were in-hospital and 12-month major adverse cardiovascular events (MACE: cardiac death, myocardial infarction or target vessel revascularization). The primary effectiveness endpoint was procedural success, defined as
- Published
- 2022
- Full Text
- View/download PDF